Cost-Effectiveness of IDegAsp in Diabetes Manag...

By Melike Belenli Gümüş

June 24, 2024

Introduction Type 2 diabetes impacts over 500 million individuals globally, leading to substantial healthcare cost...
Understanding the Cost and Clinical Impact of Multisystem Inflammatory Syndro...
Striking the Balance: Optimising Hepatitis B Treatment Strategies in The Gambia
Cost-Utility and Cost-Effectiveness of Disease-Modifying Drugs for Relapsing-...
Enhancing Surgical Recovery Predictions with AI: A New Approach
Cost Savings on Generic Drugs: Transparent Pricing Models
The Economic Burden of Knee Arthroplasty Revisions: A Cost Analysis from Türkiye
The Impact of Time Horizons on QALY Calculations in Healthcare
The Power of Real-World Evidence: Bringing Everyday Health Data to Drug Appro...
Healthcare Decision-Making with MCDA Framework: The Saudi Arabian Perspective
Prevention is Better Than Cure: The Costs of the Pandemic Accord
Economic Evaluations for Dementia Interventions
Health equity insights for National Cancer Survivors Day